Innovating in medtech is tough. You don’t have to do it alone. - Critical information is gatekept by industry insiders - Consultants aren't cheap, and finding the right ones is challenging - Accessing networks and key partners is expensive and too dependent on luck - There's no place to learn the right depth on the right topics in the right order XO Medtech solves these pain points for medtech innovators. - Membership based community with live events, workshops, and networking - The Playbook: self paced, on demand course with 40+ high impact lessons - Video walkthroughs and downloadable templates, tools, and checklists - Affordable annual membership: All access. One Price. Increase your luck surface area. Avoid early mistakes. Save time. Reduce costs. Welcome to the future of medtech innovation. Join the XO Medtech community and go further, faster, together. Get early access at www.xomedtech.com #medtech #startup #medtechinnovation #medicaldevice #lifescience #innovation #XOmedtech
XO Medtech
Education
The #1 network for medtech innovators to learn, grow and build successful ventures that shape the future of healthcare.
About us
XO is an affordable, curated, functional guide to success for medtech innovators looking to grow their skills and further their impact. The XO Community is a one of a kind space to engage with fellow innovators, share ideas, seek advice, and collaborate. Live workshops, expert interviews, and virtual pitch events drive value and a true sense of camaraderie. Inside the community is the XO Playbook: a self paced, on-demand course with 40+ lessons covering key topics like regulatory strategy, IP, prototyping, healthcare economics, customer discovery, and capital strategy. The XO Playbook leverages video walkthroughs, custom graphics, and engaging content to maximize impact and retention. Actionable templates, guides, and checklist get you moving in the right direction with velocity. The current innovation lifecycle for medtech is opaque and overwhelming. There are a million things to master, and most of them take time and resources. XO cuts through the fog to focus your efforts on initiatives that truly drive value. It equips you with the tools and knowledge to accomplish what high-dollar consultants would charge thousands to do for you. Welcome to the future of medtech innovation.
- Industry
- Education
- Company size
- 2-10 employees
- Headquarters
- Global
- Type
- Privately Held
- Founded
- 2024
Locations
-
Primary
Get directions
Global, US
Employees at XO Medtech
-
Spencer Jones
Clinician entrepreneur. Medical device leader. Innovation community builder.
-
Joshua Upshaw
Entrepreneurship Fellow | Doctoral Candidate of Experimental Psychology | Cognitive Neuroscientist | Health Tech Innovator
-
Henisha S.
Biomedical Innovation and Development Graduate from Georgia Tech
-
Amber Neil
Helping medtech innovators build valuable companies
Updates
-
Huge shoutout to XO member Ferhan Jemal for raising pre-seed capital to bring his innovation to reality. LET'S GO!! https://lnkd.in/gJGDd57g
-
🎙️ New Episode Alert: The MedTech Innovation Podcast "The secrets inside big medtech companies [how they really innovate] " Spencer Jones is joined by Brad Shirley, a 20+ year medtech veteran who's seen both sides - from billion-dollar corporate to early-stage startup. Now he's helping founders avoid the pitfalls that kill good technology. We dive deep into: → Why great technology often "dies on the vine" (and how to prevent it) → The customer discovery hack most startups overlook → How to cut prototyping costs without sacrificing quality → The truth about corporate partnerships (from someone who's been inside) 🔥 Must-listen if you're: → Building your first MVP → Looking for strategic partners → Managing limited R&D budget → Trying to nail customer discovery Brad's Reality Check: "First dollars are way harder than last dollars. Getting to the 50-yard line on your fundraising opens up all sorts of opportunities." Want to know how the big players think? Brad breaks down exactly how strategics like Cook Medical evaluate early-stage technologies and what makes them excited about partnerships. This episode is literally a peak inside the corporate playbook for startups. Don't build blind. Link to full episode in comments 👇 #medtech #startup #innovation #medicaldevices #entrepreneurship DCMS Solutions
-
Access to free tools and templates below👇
This is the most important thing and no one does it. Because its hard work. Talking to your customer. I’ve spent 100s of hours doing customer discovery. I’m giving away the secrets to my process to make it suck less. There is no other way to develop insights on your customer. Their pain points, constraints, friction, needs. All while building relationships. Build it with them, not for them. Use these tools and this workflow to supercharge your discovery efforts. To get the custom prompt and customer discovery template I use in the video, DM me “Discovery” and I'll send you the link 🔗 #medtech #customerdiscovery #freetools #worksmarter
-
OMG
Breaking News in #MedTech today. Stryker has announced its agreement to acquire Inari Medical for $4.9 billion. Each year, venous thromboembolism (VTE) impacts up to 900,000 lives in the United States and even more globally. Here’s what you need to know: ✅ Strengthening Peripheral Vascular Care: Inari’s cutting-edge solutions for venous thromboembolism (VTE) will complement Stryker’s Neurovascular portfolio, addressing a critical unmet need for non-thrombolytic clot removal. ✅ Expanding Impact: This acquisition bolsters Stryker’s position in endovascular care, improving outcomes for patients with conditions like deep vein thrombosis and pulmonary embolism. ✅ Strategic Growth: The transaction is expected to close by Q1 2025, positioning Stryker for accelerated innovation and global reach in life-saving technologies.
Stryker announces definitive agreement to acquire Inari Medical, Inc., providing entry into high-growth peripheral vascular segment
globenewswire.com
-
XO Medtech reposted this
Big news from BiVACOR: The Total Artificial Heart (TAH) was successfully implanted in 5 patients July-November 2024 as part of an FDA Early Feasibility Study—and the FDA just greenlit expanding the trial to an additional 15 patients. This breakthrough isn’t just innovation—it’s life-changing. With every step, BiVACOR is redefining future possibilities for patients battling end-stage heart failure. Read the full press release here: https://lnkd.in/dNksZPCN #BiVACOR #HealthcareInnovation #ArtificialHeart #FDAApproval
BiVACOR Total Artificial Heart Successfully Implanted in Five Patients as Part of FDA Early Feasibility Study; FDA Greenlights Expansion of the EFS
businesswire.com
-
I am giving away free tools to make 2025 the year of the medtech innovator. 3 FREE gifts to help you build valuable medtech companies this year: 1. Free training: How to build a successful medtech venture. 5 lessons for everything you need to know to get started. Get access here: https://lnkd.in/gd4xQewh 2. Free Development Roadmap Tool: Have an idea? Get the development roadmap, competitors, market insights and testing plan overview. You can share this with investors, your team, partners. It takes 5 minutes. Get access here: https://lnkd.in/edXigduv 3. Free Trial to XO Network: Get trainings, workshops, templates and an innovator network to go further, faster today. Get access here: https://xomedtech.com/ If you don't get started, someone else will. It's incredible what you can do in 1 year. I'm cheering for you.
-
-
Fastest Growing Medtech Markets in 2025 1. Pulsed field ablation (PFA): 80.7% 2. Intravascular lithotripsy (IVL): 23.6% 3. Transcatheter mitral valve (TMVR): 23.3% 4. Renal denervation (RDN): 22% 5. Transcatheter pulmonary valve: 21.9% Full article from LSI: https://lnkd.in/evra_vZa If you want to innovate in medtech in 2025, I put together an entire playbook on what it take to build successful companies. It's completely free. Get your copy here: https://lnkd.in/gd4xQewh It's the giving season. 2025 is the year you leave your mark on medtech.
-
-
XO Medtech reposted this
Here’s a clip of how EasyWhip® works! The two parts of the needle are disconnected and positioned around the tissue, allowing the suture to pass underneath. Once connected at the top and passed through the tissue, both suture tails simultaneously go through the same hole forming a whip stitch. EasyWhip®’s two-part design also enables a unique locking mechanism (the WhipLock™ stitch). By passing the needle components back through the loops before tensioning, users achieve enhanced biomechanical security. #EasyWhip #softtissuestitching #WhipIt!